[1]
2016. Exploring prognostic factors for HER2-positive metastatic breast cancer: a retrospective cohort study in a major Swiss hospital. Swiss Medical Weekly. 146, 5152 (Dec. 2016), w14393. DOI:https://doi.org/10.4414/smw.2016.14393.